570 related articles for article (PubMed ID: 23454684)
41. 4-Iminooxazolidin-2-One as a Bioisostere of Cyanohydrin Suppresses EV71 Proliferation by Targeting 3C
Xu B; Liu M; Ma S; Ma Y; Liu S; Shang L; Zhu C; Ye S; Wang Y
Microbiol Spectr; 2021 Dec; 9(3):e0102521. PubMed ID: 34787443
[TBL] [Abstract][Full Text] [Related]
42. Systematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71.
Zhu Z; Qi Y; Fan H; Cui L; Shi Z
Biomed Res Int; 2016; 2016():4302470. PubMed ID: 27843944
[TBL] [Abstract][Full Text] [Related]
43. Potential of a bivalent vaccine for broad protection against enterovirus 71 and coxsackie virus 16 infections causing hand, foot, and mouth disease.
Yi EJ; Kim YI; Song JH; Ko HJ; Ahn SH; Lee HJ; Suh B; Yu J; Park J; Lee YJ; Jung EJ; Chang SY
Vaccine; 2023 Sep; 41(41):6055-6063. PubMed ID: 37648607
[TBL] [Abstract][Full Text] [Related]
44. Enterovirus type 71-immunized chicken egg yolk immunoglobulin has cross antiviral activity against coxsackievirus A16
Gao E; Wu S; Xu Q; Zeng Y; Tan N; He S; Yang Y; Wei J
Exp Ther Med; 2019 Jul; 18(1):332-341. PubMed ID: 31258670
[TBL] [Abstract][Full Text] [Related]
45. ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway.
Yang Q; Wu C; Zhu G; Ren F; Lin B; Huang R; Hu X; Zhao D; Peng K; Wu Y; Wang Q; Huang C; Zhang D
Antiviral Res; 2023 Jan; 209():105498. PubMed ID: 36563943
[TBL] [Abstract][Full Text] [Related]
46. [Study on optimal harvest time of semi-wild Glycyrrhiza uralensis at Liangwai, Inner Mongolia].
Qiao'e W; Wenshen W; Jishu Z; Senchun F; Xiaoru W
Zhong Yao Cai; 2004 Apr; 27(4):235-7. PubMed ID: 15307678
[TBL] [Abstract][Full Text] [Related]
47. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
[TBL] [Abstract][Full Text] [Related]
48. Antiviral effects of the petroleum ether extract of
Huang X; Li J; Hong Y; Jiang C; Wu J; Wu M; Sheng R; Liu H; Sun J; Xin Y; Su W
Front Pharmacol; 2022; 13():999798. PubMed ID: 36523495
[TBL] [Abstract][Full Text] [Related]
49. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection.
Zhang W; Tao J; Yang X; Yang Z; Zhang L; Liu H; Wu K; Wu J
Biochem Biophys Res Commun; 2014 Jul; 449(3):307-12. PubMed ID: 24845570
[TBL] [Abstract][Full Text] [Related]
50. Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases.
Yuan M; Yan J; Xun J; Chen C; Zhang Y; Wang M; Chu W; Song Z; Hu Y; Zhang S; Zhang X
Virol J; 2018 Jan; 15(1):1. PubMed ID: 29298696
[TBL] [Abstract][Full Text] [Related]
51. Screening bioactive components of Glycyrrhiza uralensis Fisch. with isolated perfused lung extraction and HPLC-ESI-MS
Zheng ZG; Xu YH; Liu F; Zhao TT; Wang RX; Huang PY; Wang RS; Yang AP; Zhu Q
J Pharm Biomed Anal; 2019 May; 169():127-132. PubMed ID: 30861404
[TBL] [Abstract][Full Text] [Related]
52. Antiviral activity of sophoridine against enterovirus 71 in vitro.
Ren G; Ding G; Zhang H; Wang H; Jin Z; Yang G; Han Y; Zhang X; Li G; Li W
J Ethnopharmacol; 2019 May; 236():124-128. PubMed ID: 30853644
[TBL] [Abstract][Full Text] [Related]
53. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
[TBL] [Abstract][Full Text] [Related]
54. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.
He SJ; Han JF; Ding XX; Wang YD; Qin CF
Int J Infect Dis; 2013 Nov; 17(11):e1025-30. PubMed ID: 23791223
[TBL] [Abstract][Full Text] [Related]
55. Differential interferon pathway gene expression patterns in Rhabdomyosarcoma cells during Enterovirus 71 or Coxsackievirus A16 infection.
Zhang W; Zhang L; Wu Z; Tien P
Biochem Biophys Res Commun; 2014 May; 447(3):550-5. PubMed ID: 24735544
[TBL] [Abstract][Full Text] [Related]
56. Immunological evaluation and comparison of different EV71 vaccine candidates.
Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
[TBL] [Abstract][Full Text] [Related]
57. Phage Display-Derived Cross-Reactive Neutralizing Antibody against Enterovirus 71 and Coxsackievirus A16.
Zhang X; Sun C; Xiao X; Pang L; Shen S; Zhang J; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
Jpn J Infect Dis; 2016; 69(1):66-74. PubMed ID: 26073737
[TBL] [Abstract][Full Text] [Related]
58. In vitro antiviral activity of medicinal mushroom Ganoderma neo-japonicum Imazeki against enteroviruses that caused hand, foot and mouth disease.
Ang WX; Sarasvathy S; Kuppusamy UR; Sabaratnam V; Tan SH; Wong KT; Perera D; Ong KC
Trop Biomed; 2021 Sep; 38(3):239-247. PubMed ID: 34362866
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of lysosome-tethered Ragulator-Rag-3D complex restricts the replication of Enterovirus 71 and Coxsackie A16.
Wang X; Hu Z; Zhang W; Wu S; Hao Y; Xiao X; Li J; Yu X; Yang C; Wang J; Zhang H; Ma F; Shi W; Wang J; Lei X; Zhang X; He S
J Cell Biol; 2023 Dec; 222(12):. PubMed ID: 37906052
[TBL] [Abstract][Full Text] [Related]
60. Construction and characterization of an infectious clone of coxsackievirus A16.
Liu F; Liu Q; Cai Y; Leng Q; Huang Z
Virol J; 2011 Dec; 8():534. PubMed ID: 22165961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
